Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
28全身性アミロイドーシス1

28. 全身性アミロイドーシス


臨床試験数 : 267 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01815086
(ClinicalTrials.gov)
December 200813/3/2013Radioimmunoimaging of Light Chain (AL) AmyloidosisRadioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody (mAb) Murine (Mu) 11-F4AL AmyloidosisBiological: Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)University of TennesseeNULLCompleted21 Years90 YearsBoth30Phase 1United States